Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The role of nitric oxide (NO) in the genesis of cerebral malaria is controversial. Most investigators propose that the unfortunate consequence of the high concentrations of NO produced to kill the parasite is the development of cerebral malaria. Here we have tested this high NO bioavailability hypothesis in the setting of experimental cerebral malaria (ECM), but find instead that low NO bioavailability contributes to the genesis of ECM. Specifically, mice deficient in vascular NO synthase showed parasitemia and mortality similar to that observed in control mice. Exogenous NO did not affect parasitemia but provided marked protection against ECM; in fact, mice treated with exogenous NO were clinically indistinguishable from uninfected mice at a stage when control infected mice were moribund. Administration of exogenous NO restored NO-mediated signaling in the brain, decreased proinflammatory biomarkers in the blood, and markedly reduced vascular leak and petechial hemorrhage into the brain. Low NO bioavailability in the vasculature during ECM was caused in part by an increase in NO-scavenging free hemoglobin in the blood, by hypoargininemia, and by low blood and erythrocyte nitrite concentrations. Exogenous NO inactivated NO-scavenging free hemoglobin in the plasma and restored nitrite to concentrations observed in uninfected mice. We therefore conclude that low rather than high NO bioavailability contributes to the genesis of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This was suggested to contribute to the pathogenesis of severe forms of malaria in mice, without interfering with host pathogen burden [192], thus arguing that NO scavenging by extracellular hemoglobin impairs disease tolerance to Plasmodium infection.”
From The Iron age of host–microbe interactions (2015) · cites this paper as [192]
In the citing paper
“The mechanisms underlying the pathogenic effects of extracellular hemoglobin were associated originally to NO scavenging, reducing NO bioavailability, and impairing microvascular homeostasis [192,196] (Fig 4).”
From The Iron age of host–microbe interactions (2015) · cites this paper as [192]
Citations
Cites
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 1×
“Thus, we posit that low NO bioavailability exacerbates underlying pathogenic processes, as observed in sickle cell diseas”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Morris, C. R. (2005) · JAMA · doi:10.1001/jama.294.1.81 · Cited by 763
Stevenson, M. M., & Riley, E. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1311 · Cited by 653
Anstey, N. M., Weinberg, J. B., Hassanali, M. Y., Mwaikambo, E. D., Manyenga, D., Misukonis, M. A., Arnelle, D. R., Hollis, D., McDonald, M. I., & Granger, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.557 · Cited by 431
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
Wagener, F. A. D. T. G., Eggert, A., Boerman, O. C., Oyen, W. J. G., Verhofstad, A., Abraham, N. G., Adema, G., van Kooyk, Y., de Witte, T., & Figdor, C. G. (2001) · Blood · doi:10.1182/blood.v98.6.1802 · Cited by 421
[26] Oxidative reactions of hemoglobin
Winterbourn, C. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86118-f · Cited by 409
van der Heyde, H. C., Nolan, J., Combes, V., Gramaglia, I., & Grau, G. E. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.09.002 · Cited by 400
Self-citation
Cited by
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2012-11-451229 · Cited by 754
Intravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria
Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, Â., Rodrigues, C. D., Gregoire, I. P., Cunha-Rodrigues, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1586 · Cited by 560
“), scavenging of nitric oxide (NO) by cell-free hemoglobin generated during malaria infection promotes the onset of ECM (ref”
BackgroundPulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J.-P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446
“The latter interpretation seems to conflict with a recent report indicating decreased bioavailability of NO in PbA infectio”
Percário, S., Moreira, D., Gomes, B., Ferreira, M., Gonçalves, A., Laurindo, P., Vilhena, T., Dolabela, M., & Green, M. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131216346 · Cited by 363
“death of the parasites [26,27] while others support the idea that cerebral malaria results from a low bioavailability of this compound [28].”
BackgroundKato, G. J., Hebbel, R. P., Steinberg, M. H., & Gladwin, M. T. (2009) · American Journal of Hematology · doi:10.1002/ajh.21475 · Cited by 349
“A state of resistance to NO mediated by cell-free plasma hemoglobin and the development of pulmonary hypertension has also been shown in transgenic mouse models of SCD and spherocytosis and in mouse models of alloimmune hemolysis and malaria [53,54].”
BackgroundThe ABO blood group system and Plasmodium falciparum malaria
Cserti, C. M., & Dzik, W. H. (2007) · Blood · doi:10.1182/blood-2007-03-077602 · Cited by 320
“Reduced NO promotes platelet activation and vWF-mediated adhesion,(95) and worsened survival in a rodent model of cerebral malaria.(96) Moreover, NO antagonists were observed to increase cytoadherence of parasitized cells to human endothelial cells under flow conditions in vitro.”
Yeo, T. W., Lampah, D. A., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y. R., Darcy, C. J., Granger, D. L., Weinberg, J. B., Lopansri, B. K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070819 · Cited by 299
Host-Parasite Interactions Revealed by Plasmodium falciparum Metabolomics
Olszewski, K. L., Morrisey, J. M., Wilinski, D., Burns, J. M., Vaidya, A. B., Rabinowitz, J. D., & Llinás, M. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.01.004 · Cited by 289
“There is substantial evidence linking hypoargininemia to malarial infection and progression to cerebral malaria (Gramaglia et al., 2006; Lopansri et al., 2003; Yeo et al., 2007), but the origin of this effect has not been established to date.”
InfluentialHammad, M., Raftari, M., Cesário, R., Salma, R., Godoy, P., Emami, S. N., & Haghdoost, S. (2023) · Antioxidants · doi:10.3390/antiox12071371 · Cited by 231
The Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
“This was suggested to contribute to the pathogenesis of severe forms of malaria in mice, without interfering with host pathogen burden [192], thus arguing that NO scavenging by extracellular hemoglobin impairs disease tolerance to Plasmodium infection.”
BRIAN de SOUZA, J., HAFALLA, J. C. R., RILEY, E. M., & COUPER, K. N. (2010) · Parasitology · doi:10.1017/s0031182009991715 · Cited by 229
A central role for free heme in the pathogenesis of severe malaria: the missing link?
Ferreira, A., Balla, J., Jeney, V., Balla, G., & Soares, M. P. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0368-5 · Cited by 205
“Plasmodium infection is associated with a profound reduction of NO bioavailability both in mice [9] and in humans [91], an effect that precipitates the onset of cerebral malaria in mice [9].”
BackgroundInfluentialMechanisms of haemolysis-induced kidney injury
Van Avondt, K., Nur, E., & Zeerleder, S. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0181-0 · Cited by 204
Boretti, F. S., Buehler, P. W., D’Agnillo, F., Kluge, K., Glaus, T., Butt, O. I., Jia, Y., Goede, J., Pereira, C. P., Maggiorini, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39115 · Cited by 196
Pulmonary Complications of Sickle Cell Disease
Miller, A. C., & Gladwin, M. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2082ci · Cited by 180
Platelet Factor 4 Mediates Inflammation in Experimental Cerebral Malaria
Srivastava, K., Cockburn, I. A., Swaim, A., Thompson, L. E., Tripathi, A., Fletcher, C. A., Shirk, E. M., Sun, H., Kowalska, M. A., Fox-Talbot, K., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.003 · Cited by 168
“One hour later brains were harvested and incubated in 10% buffered formalin for 48 hr, and dye extravasation determined by optical density (Gramaglia et al., 2006).”
MethodThe immunological balance between host and parasite in malaria
Deroost, K., Pham, T., Opdenakker, G., & den Steen, P. E. V. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv046 · Cited by 182
Hemoglobin-mediated nitric oxide signaling
Helms, C., & Kim-Shapiro, D. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.028 · Cited by 146
“In addition, NO scavenging by cell-free hemoglobin is also implicated in pathology in hemolytic anemias like sickle cell disease [8,57,58], malaria [59-61], and transfusion of older stored blood [9].”
BackgroundCerebral malaria: Mysteries at the blood-brain barrier
Rénia, L., Howland, S. W., Claser, C., Gruner, A. C., Suwanarusk, R., Teo, T.-H., Russell, B., & Ng, L. F. P. (2012) · Virulence · doi:10.4161/viru.19013 · Cited by 137
“PbA IRBC sequestration in mice is essential for ECM to occur since drug treatment just before neurological signs are expected prevents ECM.57–59 Sequestration is higher in susceptible C57BL/6J at the time of ECM signs than in resistant BALB/ cJ mice (Claser and Renia, unpublished results) and is regulated by CD8+ T ce…”
InfluentialYeo, T. W., Lampah, D. A., Tjitra, E., Gitawati, R., Kenangalem, E., Piera, K., Granger, D. L., Lopansri, B. K., Weinberg, J. B., Price, R. N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/644641 · Cited by 132
“Reduced NO bioavailability in malaria contributes to increased endothelial activation, increased cytoadherence of parasitized erythrocytes, and impaired vasomotor regulation [3, 4], and it is associated with increased mortality in murine malaria [5] and disease severity in both adults and children [3, 6].”
Yu, B., Ichinose, F., Bloch, D. B., & Zapol, W. M. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14512 · Cited by 134
“NO improved survival by inactivating NO-scavenging by free Hb in the plasma (Gramaglia et al., 2006).”
BackgroundPathophysiology and neurologic sequelae of cerebral malaria
Schiess, N., Villabona-Rueda, A. F., Cottier, K. E., Huether, K., Chipeta, J., & Stins, M. F. (2020) · Malaria Journal · doi:10.1186/s12936-020-03336-z · Cited by 144
Aliyu, Z. Y., Kato, G. J., Taylor, J. G., Babadoko, A., Mamman, A. I., Gordeuk, V. R., & Gladwin, M. T. (2007) · American Journal of Hematology · doi:10.1002/ajh.21057 · Cited by 127
“Acute and chronic malarial infections are associated with intravascular hemolysis and a depletion of NO associated with intravascular hemolysis has been described in animal models, supporting a mechanism similar to that of hemolysis-associated vasculopathy as in SCD [49].”
ResultCabrales, P., Zaniní, G. M., Meays, D. R., Frangos, J. A., & Carvalho, L. J. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir058 · Cited by 109
“Indeed, DPTA-NO treatment, although causing a shortlived drop in blood pressure right after injection, in the long run actually offsets the hypotension observed during PbA infection [15].”
BackgroundInfluentialSelf-citationPULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children
Kato, G. J., Onyekwere, O. C., & Gladwin, M. T. (2007) · Pediatric Hematology and Oncology · doi:10.1080/08880010601185892 · Cited by 110
“A similar mechanism also may pertain in malaria and paroxysmal nocturnal hemoglobinuria [40, 41].”
BackgroundUnderstanding the role of inflammatory cytokines in malaria and related diseases
Clark, I. A., Alleva, L. M., Budd, A. C., & Cowden, W. B. (2007) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2007.07.002 · Cited by 110
Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections
Geurts, N., Opdenakker, G., & den Steen, P. E. V. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.008 · Cited by 119
Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis
Schaer, C. A., Deuel, J., Schildknecht, D., Mahmoudi, L., García‐Rubio, I., Owczarek, C. M., Schauer, S., Kissner, R., Banerjee, U., Palmer, A. F., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2058oc · Cited by 113
Aliyu, Z. Y., Gordeuk, V., Sachdev, V., Babadoko, A., Mamman, A. I., Akpanpe, P., Attah, E., Suleiman, Y., Aliyu, N., Yusuf, J., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21162 · Cited by 105
“Hemolysis associated with malaria produces a similar state of endothelial dysfunction secondary to NO scavenging by cell free hemoglobin and plasma arginase as that seen in SCD [7,9].”
Fenozyme Protects the Integrity of the Blood–Brain Barrier against Experimental Cerebral Malaria
Zhao, S., Duan, H., Yang, Y., Yan, X., & Fan, K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03774 · Cited by 103
den Steen, P. E. V., Deroost, K., Aelst, I. V., Geurts, N., Martens, E., Struyf, S., Nie, C. Q., Hansen, D. S., Matthys, P., Damme, J. V., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737906 · Cited by 100
Cabrales, P., Zaniní, G. M., Meays, D. R., Frangos, J. A., & Carvalho, L. J. M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090691 · Cited by 99
Self-citationArginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria
Weinberg, J. B., Lopansri, B. K., Mwaikambo, E. D., & Granger, D. L. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32830ef5cf · Cited by 105
Schaer, D. J., & Buehler, P. W. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013433 · Cited by 96
“In the acute phase of severe malaria, hemolysis appears to exaggerate inflammatory processes and endothelial damage through NO depletion, oxidation, and inflammation (Gramaglia et al. 2006; Pamplona et al. 2007).”
BackgroundKato, G. J., Wang, Z., Machado, R. F., Blackwelder, W. C., Taylor, J. G., & Hazen, S. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07658.x · Cited by 100
“A similar pathophysiology is observed in other animal models of haemolysis and other human haemolytic diseases (Minneci et al, 2005; Rother et al, 2005; Gramaglia et al, 2006; Hsu et al, 2007).”
BackgroundMolecular Basis of Health and Disease
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4 · Cited by 104
Polimeni, M., & Prato, M. (2014) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-11-1 · Cited by 88
“Similarly, van der Heyde and his group demonstrated that low NO bioavailability was associated with murine CM [78,79].”
BackgroundReversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide
Cabrales, P., Han, G., Nacharaju, P., Friedman, A. J., & Friedman, J. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00665.2010 · Cited by 86
“strated, but a practical mechanism to administer NO remains to be defined (16).”
BackgroundShikani, H. J., Freeman, B. D., Lisanti, M. P., Weiss, L. M., Tanowitz, H. B., & Desruisseaux, M. S. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.010 · Cited by 82
Serghides, L., Kim, H., Lu, Z., Kain, D. C., Miller, C., Francis, R. C. E., Liles, W. C., Zapol, W. M., & Kain, K. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027714 · Cited by 87
“reported in data not shown that NO gas also had a protective effect [74].”
BackgroundResultInteractions of the malaria parasite and its mammalian host
Silvie, O., Mota, M. M., Matuschewski, K., & Prudêncio, M. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.06.005 · Cited by 79
Yeo, T. W., Lampah, D. A., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C. J., Granger, D. L., Weinberg, J. B., Lopansri, B. K., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590209 · Cited by 88
“An animal model of severe malaria has recently shown that increasing NO bioavailability improves survival [42].”
BackgroundDistinct Clinical and Immunologic Profiles in Severe Malarial Anemia and Cerebral Malaria in Zambia
Thuma, P. E., van Dijk, J., Bucala, R., Debebe, Z., Nekhai, S., Kuddo, T., Nouraie, M., Weiss, G., & Gordeuk, V. R. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jiq041 · Cited by 77
“Nitric oxide deficiency, in part because of increased nitric oxide scavenging by free plasma hemoglobin, may contribute to experimental cerebral malaria in mice [50].”
BackgroundPleiotropic effects of intravascular haemolysis on vascular homeostasis
Kato, G. J., & Taylor, J. G. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08004.x · Cited by 87
Does activation of the blood coagulation cascade have a role in malaria pathogenesis?
Francischetti, I. M. B. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.03.009 · Cited by 82
Contrasting pediatric and adult cerebral malaria: The role of the endothelial barrier
Hawkes, M., Elphinstone, R. E., Conroy, A. L., & Kain, K. C. (2013) · Virulence · doi:10.4161/viru.25949 · Cited by 79
Widmer, C. C., Pereira, C. P., Gehrig, P., Vallelian, F., Schoedon, G., Buehler, P. W., & Schaer, D. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2826 · Cited by 72
“Extracellular Hb has been implicated in the pathogenesis of hemolytic diseases such as sickle cell anemia or malaria and also in more localized processes such as in atherosclerosis with associated intraplaque hemorrhage (1, 6, 8, 18, 22, 35).”
BackgroundHiggins, S. J., Kain, K. C., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.96 · Cited by 77
Cerebral malaria – clinical manifestations and pathogenesis
Hora, R., Kapoor, P., Thind, K. K., & Mishra, P. C. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-015-9787-5 · Cited by 84
“…evidences argue against the association of high NO bioavailability with disease severity, and instead indicate it to be low during CM. Low NO bioavailability may result from NO scavenging by cell free hemoglobin and superoxides in plasma, or even due to hypoargininaemia (Gramaglia et al. 2006 ).”
BackgroundEndothelial activation and dysregulation in malaria: a potential target for novel therapeutics
Kim, H., Higgins, S. J., Liles, W. C., & Kain, K. C. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328345a4cf · Cited by 76
Tryps and trips: cell trafficking across the 100-year-old blood–brain barrier
Bentivoglio, M., & Kristensson, K. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.03.007 · Cited by 71
He, X., Yan, J., Zhu, X., Wang, Q., Pang, W., Qi, Z., Wang, M., Luo, E., Parker, D. M., Cantorna, M. T., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400089 · Cited by 71
“The amount of Evans blue in 100 ml of the brain tissue extracts was determined by measuring absorbance at 630 nm (27).”
Ferrari, C. K. B., Souto, P. C. D. S., França, E. L., & Honório‐França, A. C. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0144-z · Cited by 84
“Still considering malaria, weaker NO production by macrophages was associated with a worst outcome of cerebral malaria (Gramaglia et al. 2006; Lopansri et al. 2003), indicating that NO is essential in parasite killing, confirming previous reports (Balmer et al. 2000; Nahrevanian 2006; Nahrevanian…”
ResultControl of Disease Tolerance to Malaria by Nitric Oxide and Carbon Monoxide
Jeney, V., Ramos, S., Bergman, M.-L., Bechmann, I., Tischer, J., Ferreira, A., Oliveira-Marques, V., Janse, C. J., Rebelo, S., Cardoso, S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.054 · Cited by 70
Rajendran, E., Hapuarachchi, S. V., Miller, C., Fairweather, S. J., Cai, Y., Smith, N. C., Cockburn, I. A., Bröer, S., Kirk, K., & van Dooren, G. G. (2017) · Nature Communications · doi:10.1038/ncomms14455 · Cited by 75
Hansen, D. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003045 · Cited by 67
“Although some interventions such as anti-TNF therapy that prevented ECM have not been effective in humans [29], other treatments such as L-arginine or NO administration appear to be protective in mice and humans [30,31].”
BackgroundInhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial
Hawkes, M., Conroy, A. L., Opoka, R. O., Hermann, L., Thorpe, K. E., McDonald, C. R., Kim, H., Higgins, S. J., Namasopo, S., John, C. C., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0946-2 · Cited by 67
“Pathways of endothelial activation and dysfunction are reflected in experimental models of severe malaria, where inhaled NO enhances endothelial integrity, reduces parasite accumulation in the brain vasculature, and improves survival [5, 18].”
BackgroundVasospasm in Cerebral Inflammation
Eisenhut, M. (2014) · International Journal of Inflammation · doi:10.1155/2014/509707 · Cited by 65
Olivera, G. C., Ren, X., Vodnala, S. K., Lu, J., Coppo, L., Leepiyasakulchai, C., Holmgren, A., Kristensson, K., & Rottenberg, M. E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005442 · Cited by 74
“Exogenous GSNO protected against ECM, decreased pro-inflammatory biomarkers in the blood and vascular leakage into the brain, without affecting levels of parasitemia [32,33].”
BackgroundEmerging roles for hemostatic dysfunction in malaria pathogenesis
O’Sullivan, J. M., Preston, R. J. S., O’Regan, N., & O’Donnell, J. S. (2016) · Blood · doi:10.1182/blood-2015-11-636464 · Cited by 77
“Previous studies reporting diminished vascular nitric oxide (NO) bioavailability in individuals with CM compared with healthy individuals further underscore the importance of dysregulated EC activation in CM pathogenesis(15) Impaired NO production promotes enhanced EC activation and IE cytoadherence(16) and is associa…”
BackgroundMartins, Y. C., Smith, M. J., Pelajo‐Machado, M., Werneck, G. L., Lenzi, H. L., Daniel‐Ribeiro, C. T., & Carvalho, L. J. M. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00622.x · Cited by 62
“In addition, a higher level of parasitaemia will result in higher amounts of free haemoglobin and free haeme released, both shown to be involved in CM pathogenesis (Gramaglia et al. 2006; Pamplona et al. 2007).”
BackgroundOng, P. K., Melchior, B., Martins, Y. C., Hofer, A., Orjuela-Sánchez, P., Cabrales, P., Zaniní, G. M., Frangos, J. A., & Carvalho, L. J. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003444 · Cited by 65
“Since low NO bioavailability and its associated vascular dysfunction are key factors contributing to ECM pathogenesis [13,17], there is a compelling need for the development of new therapeutic approaches targeting the restoration of both NO bioavailability and cerebrovascular function for ECM treatment.”
BackgroundSelf-citationBeta Interferon Suppresses the Development of Experimental Cerebral Malaria
Morrell, C. N., Srivastava, K., Swaim, A. F., Lee, M. T., Chen, J., Nagineni, C. N., Hooks, J. J., & Detrick, B. (2011) · Infection and Immunity · doi:10.1128/iai.00810-10 · Cited by 55
“malin for 48 h, and dye extravasation was determined by optical density (6).”
MethodArginine Cools the Inflamed Gut
Fritz, J. H. (2013) · Infection and Immunity · doi:10.1128/iai.00789-13 · Cited by 56
“the brain, and provided marked protection (19).”
Host resistance to malaria: using mouse models to explore the host response
Longley, R. J., Smith, C. M., Fortin, A., Berghout, J., McMorran, B. J., Burgio, G., Foote, S. J., & Gros, P. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9302-6 · Cited by 64
“Sickle cell anemia Early clearance of infected RBCs Ayi et al. 2004; Fortin et al. 2002; Friedman 1978”
BackgroundZaniní, G. M., Cabrales, P., Barkho, W., Frangos, J. A., & Carvalho, L. J. M. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-66 · Cited by 51
“In the murine model of CM by P. berghei ANKA (PbA), the neurological syndrome is associated with several indicators of severe vasculopathy and endothelial dysfunction, whose pathogenesis is complex and involves a systemic inflammatory response with activation of CD4+ and CD8+ T cells, macrophages, platelets, release o…”
BackgroundInfluentialSelf-citationIncreased Pulmonary Pressures and Myocardial Wall Stress in Children with Severe Malaria
Janka, J., Koita, O., Traoré, B., Traoré, J. M., Mzayek, F., Sachdev, V., Wang, X., Sanogo, K. M., Sangaré, L., Mendelsohn, L. G., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655225 · Cited by 50
“Taken together, the evidence that NO treatment reduces malaria mortality in mice [21], and the results reported here and by other investigators [23, 45] suggest that it may be possible to reduce the deaths that occur early in the hospital course of children with severe malaria [47] by using treatment strategies that i…”
BackgroundHempel, C., Combes, V., Hunt, N. H., Kurtzhals, J. A. L., & Grau, G. E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.027 · Cited by 50
Gramaglia, I., Velez, J., Combes, V., Grau, G. E., Wree, M., & van der Heyde, H. C. (2017) · Blood · doi:10.1182/blood-2016-08-733519 · Cited by 47
Self-citationNahrevanian, H. (2009) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702009000600010 · Cited by 52
“[64].”
Nrf2 as a master regulator of tissue damage control and disease tolerance to infection
Soares, M. P., & Ribeiro, A. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150054 · Cited by 48
Genetics of Malaria Inflammatory Responses: A Pathogenesis Perspective
Penha‐Gonçalves, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01771 · Cited by 48
Haselden, W. D., Kedarasetti, R. T., & Drew, P. J. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008069 · Cited by 51
Perera, M. K. T., Herath, N., Pathirana, S., Phone-Kyaw, M., Alles, H. K., Mendis, K., Premawansa, S., & Handunnetti, S. (2013) · Pathogens and Global Health · doi:10.1179/2047773212y.0000000069 · Cited by 43
Nyariki, J. N., Ochola, L. B., Jillani, N., Nyamweya, N. O., Amwayi, P. W., Yole, D., Azonvide, L., & Isaac, A. O. (2019) · Parasitology International · doi:10.1016/j.parint.2019.04.010 · Cited by 46
Dowling, D., Ilies, M., Olszewski, K. L., Portugal, S., Mota, M. M., Llinás, M., & Christianson, D. W. (2010) · Biochemistry · doi:10.1021/bi100390z · Cited by 44
“Malaria patients often present with hypoargininemia (10, 11), and metabolomic studies of P.”
Martins, Y. C., Zaniní, G. M., Frangos, J. A., & Carvalho, L. J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032048 · Cited by 46
“of both human and experimental CM [15,16,20,49].”
BackgroundMethodInfluentialSelf-citationHawkes, M., Opoka, R. O., Namasopo, S., Miller, C., Thorpe, K. E., Lavery, J. V., Conroy, A. L., Liles, W. C., John, C. C., & Kain, K. C. (2011) · Trials · doi:10.1186/1745-6215-12-176 · Cited by 39
“In summary, a clinical trial of adjunctive inhaled nitric oxide (iNO) in severe malaria is warranted on the basis of firm proof of concept from animal models [ 11 ] and a clinical trial using the NO donor L-arginine [36], together with evidence of safety from clinical experience and numerous clinical trials of iNO for…”
BackgroundInfluentialDietmann, A., Lackner, P., Helbok, R., Spora, K., Issifou, S., Lell, B., Reindl, M., Kremsner, P. G., & Schmutzhard, E. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-253 · Cited by 38
“Gramaglia et al could recently show that low NO bioavailability contributes to the genesis of murine cerebral malaria and mice treated with exogenous NO did not develop severe malaria [38].”
BackgroundGrab, D. J., Chakravorty, S. J., van der Heyde, H., & Stins, M. F. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01661.x · Cited by 35
“In CM, NO released from the BBB can have a dual effect; luminal released NO is quenched by free haemoglobin and reactive oxygen species and therefore results in a low peripheral NO bioavailability (Gramaglia, 2006).”
BackgroundMwanga‐Amumpaire, J., Carroll, R. W., Baudin, E., Kemigisha, E., Nampijja, D., Mworozi, K., Santorino, D., Nyehangane, D., Nathan, D. I., Beaudrap, P. D., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv111 · Cited by 41
“million (ppm) of inhaled NO [19, 20] improved survival rates, reduced plasma inflammatory markers, and increased plasma Ang-1 levels.”
BackgroundHemolysis and Kidney Injury in Cardiac Surgery: The Protective Role of Nitric Oxide Therapy
Spina, S., Lei, C., Pinciroli, R., & Berra, L. M. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.06.008 · Cited by 38
Clark, I. A., Budd, A. C., & Alleva, L. M. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-208 · Cited by 35
“This dichotomy may prove to explain why both NO and CO are anti-inflammatory in mice, including protecting against the mouse model of malaria encephalopathy [36,37], whereas H2S is pro-inflammatory, increasing plasma TNF levels in mice [38], and its inhibition protects in sepsis models [38,39].”
BackgroundHyperbaric Oxygen Prevents Early Death Caused by Experimental Cerebral Malaria
Blanco, Y. C., Farias, A. S., Gölnitz, U., Lopes, S. C. P., Arrais-Silva, W. W., Carvalho, B. O., Amino, R., Wunderlich, G., dos Santos, L. M. B., Giorgio, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003126 · Cited by 33
“To investigate whether HBO therapy could improve poor ECM outcomes, we measured the corporal PLoS ONE | www.plosone.org 5 September 2008 | Volume 3 | Issue 9 | e3126 PLoS ONE | www.plosone.org 6 September 2008 | Volume 3 | Issue 9 | e3126 temperature of PbA-infected mice daily regardless of exposure to pressurized oxy…”
BackgroundInfluentialPathogenetic mechanisms and treatment targets in cerebral malaria
Hadjilaou, A., Brandi, J., Riehn, M., Friese, M. A., & Jacobs, T. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00881-4 · Cited by 41
“In mouse models of cerebral malaria, various strategies that increase nitric oxide levels are associated with reduced mortality 171–175 .”
BackgroundInfluentialNdunge, O. B. A., Kilian, N., & Salman, M. M. (2022) · Advanced Science · doi:10.1002/advs.202202944 · Cited by 47
Bertinaria, M., Guglielmo, S., Rolando, B., Giorgis, M., Aragno, C., Fruttero, R., Gasco, A., Parapini, S., Taramelli, D., Martins, Y. C., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.029 · Cited by 32
S-nitrosoglutathione Prevents Experimental Cerebral Malaria
Zaniní, G. M., Martins, Y. C., Cabrales, P., Frangos, J. A., & Carvalho, L. J. M. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9343-6 · Cited by 36
“The high dose of DPTA-NO effective in preventing ECM (1 mg/ mouse), combined with a fast and short-lived release of NO by DPTA-NO in aqueous solutions, results in the generation of a huge amount of NO in a short period of time, which leads to the occurrence of acute side effects such as marked hypotension (Gramaglia e…”
InfluentialSelf-citationVascular dysfunction as a target for adjuvant therapy in cerebral malaria
Carvalho, L. J. M., Moreira, A. D. S., Daniel‐Ribeiro, C. T., & Martins, Y. C. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276140061 · Cited by 34
“Inhaled NO is an alternative with therapeutic potential and shown to be effective in both preventing ECM as well as an adjunctive therapy with artesunate (Gramaglia et al. 2006, Serghides et al. 2011).”
InfluentialMalaria and hypertension. Another co-evolutionary adaptation?
Gallego‐Delgado, J., & Rodríguez, A. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00121 · Cited by 34
“Funding was provided by FECYT (mobility program), Ministry of Education of Spain for Julio Gallego-Delgado.”
MethodMartins, Y. C., Carvalho, L. J. M., & Daniel‐Ribeiro, C. T. (2009) · NeuroImmunoModulation · doi:10.1159/000180268 · Cited by 32
Erythropoietin Protects against Murine Cerebral Malaria through Actions on Host Cellular Immunity
Xu, W., Li, Y., Sun, X., Zhu, X., Feng, Y., Liu, J., Jiang, Y., Shang, H., Cui, L., & Cao, Y. (2013) · Infection and Immunity · doi:10.1128/iai.00929-13 · Cited by 33
“mined by measuring absorbance at 620 nm (31).”
BackgroundOnalo, R., Cilliers, A. M., Cooper, P., & Morris, C. R. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1930oc · Cited by 37
Brant, F., de Miranda, A. S., Esper, L., Rodrigues, D. H., Kangussu, L. M., Bonaventura, D., Soriani, F. M., Pinho, V., Souza, D. G., Rachid, M. A., et al. (2014) · Infection and Immunity · doi:10.1128/iai.01733-14 · Cited by 30
NO and CO binding profiles of hemoglobin vesicles as artificial oxygen carriers
Sakai, H., Sato, A., Sobolewski, P., Takeoka, S., Frangos, J. A., Kobayashi, K., Intaglietta, M., & Tsuchida, E. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.03.007 · Cited by 28
Self-citationAlkaitis, M. S., Wang, H., Ikeda, A. K., Rowley, C. A., MacCormick, I. J. C., Chertow, J. H., Billker, O., Suffredini, A. F., Roberts, D. J., Taylor, T. E., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw452 · Cited by 28
Trovoada, M. J., Martins, M., Mansour, R. B., Sambo, M. D. R., Fernandes, A. B., Gonçalves, L. A., Borja, A., Moya, R., Almeida, P., Costa, J., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01070-13 · Cited by 27
“Nevertheless, NO anti-inflammatory properties have been claimed to prevent cerebral malaria (3, 41), and epidemiological evidence is accumulating that NO plasma levels are decreased in cerebral malaria (6, 11, 12, 38).”
BackgroundKrajewski, M. L., Hsu, L. L.-Y., & Gladwin, M. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2008 · Cited by 31
“Low NO bioavailability has been implicated in the development of experimental cerebral malaria (12).”
Background
Metadata
- Authors
- Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J. P., Frangos, J. A., Intaglietta, M., & van der Heyde, H. C.
- Affiliations
- La Jolla Bioengineering Institute (US)
- Venue
- Nature Medicine
- Published
- 2006-11-12
- Volume
- 12
- Issue
- 12
- Pages
- 1417-1422
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2095371540
- Cited by
- 215
- References
- 31
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 14 · 2016: 11 · 2015: 11 · 2014: 13 · 2013: 20 · 2012: 15
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL040696, HL40696, R24 HL 643952)
- National Institute of Allergy and Infectious Diseases (R01AI040667, AI 40667)
- National Institute of Biomedical Imaging and Bioengineering (EB003824, R01EB003824)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- cerebral malaria, nitric oxide bioavailability, exogenous nitric oxide, malaria, free hemoglobin, nitrite, vascular leakage, petechiae, pro-inflammatory markers, cerebral vasculature, Plasmodium falciparum
- MeSH terms
- Alkenes, Animals, Arginine, Blood Pressure, Capillary Permeability, Cyclic GMP, Hemoglobins, Mice, Inbred C57BL, Models, Biological, Nitric Oxide, Nitrites, Plasmodium berghei, Tissue Distribution, Malaria, Cerebral, Mice, Knockout, Models, Animal, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.